Antibiotics Flashcards
Q-SOFA
Resp rate >22
Altered GCS
Systolic BP <100
Sepsis
If vasopressors required to maintain MAP >65 +
Serum lactate > 2
Abnormalities in sepsis
FBC = WBC >12 or <4, Plt <100
U+E = Cr >310, acute oliguria <0.5ml/kg/hr
Lactate >2
Coag = PTT > 60, INR >1.5
Gram +ve bacteria
Cocci - staphylococcus (aureus and epidermis), streptococcus (pyogenes and pneumoniae), enterococcus
Rods - listeria, bacillus
Stain purple on gram stain
Gram -ve bacteria
Cocci - nessieria meningitides, gonorrhoea, bordetella
Rods - e.coli, Hib, pseudomonas, klebsiella
coliforms - enterococcus, salmonella, shigella
Stain pink
Don’t gram stain
Lack of a cell wall - mycoplasma, chlamydia, and mycobacterium TB
Antibiotic targets
Cell wall - B lactams, glycopeptides
Protein synthesis - macrocodes, tetracyclines, ahminoglycosides and clindamycin
Folate (DNA synthesis) - trimethoprim and sulphonamides
Nucleic acids - DNA = metronidazole, RNA - rifampicin
B-lactams
Encompasses the penicillins, cephalosporins and the carbopenams. All act to inhibit cell wall formation by inhibition of NAMA and NAG cross linking peptoglycan. This leads to weakness and lysis of the cell
Uses of penicillins
Flucloxicillin = cellulitis and skin infections
Amox/coamox = LRTI, UTI, URTI
Sepsis = Tazocin
Bacterial meningitis = Ben Pen
SE of penicillins
Generally well tolerated - GI upset diarrhoea and risk of c.diff esp with co-amox.
Hypersensitivity - skin rash, anaphylaxis, SJS, TIN
Fluxcloxicillin + coamoxiclav - cholestatic jaundice
Amoxicillin + EBV (glandular fever) = widespread maculopapular rash
Interactions of penicillins
Reduce efficacy of COCP, may increase INR due CY450 inhibitor effects
Generations of cephalosporins
1st - ceflaxin
2nd - cefuroxime
3rd - cefotaxime and ceftriaxone
1st generations = good cover against gram +ve
3rd = increased gram -ve cover
Indications of cephalosporins
Ceftriaxone - bacterial meningitis will penetrate meninges if they are inflamed
Bilary tract - cefuroxime
LRTI and epiglottis - cefotaxime
SE cephalosporins
10% cross reactivity with penicillin allergic!
Hypersensitivity - SJS and TEN
High c.diff risk!
Carbopenams
Meropenam and ertapenam. Broadest spectrum Abx against gram +ve, gram -ve and anaerobes
Indications for carbopenams
Pseudomonas infection
Complicated UTI/URTI
SE of carbopenams
N/V and diarrhoea - 5%, neurotoxicity and seizures esp in high doses or renal failure
Tetracyclines MOA
Target 30s ribosomal subunit reversibly binds blocking tRNA binding. It dose this by inhibiting aminoacyl tRNA and mRNA complex formation. Bacteriostatic - prevents replication
Indications for tetracyclines
Malaria prophylaxis
Mixed respiratory tract infections
Lymes(c.burnetti), brucella, chlamydia
Acne vulgaris/rosacea
Interactions of tetracyclines
Antacids, oral iron replacement and dairy products reduces their absorption and therefore efficacy
Risk of idiopathic intracranial HTN with retinoids
CYP450 inhibitors
SE tetracyclins
CI in children and pregnancy due to dental hypoplasia causing brown stained teeth and weak bones
Photosensitivity
Can cause oesophageal irritation and dysphagia
Aminoglycosides
Gentamicin and streptomycin
MOA aminoglycosides
Inhibit protein synthesis by triple blockade
i - misreading of mRNA
ii - block formation of initiation complex of peptide chain on 30s subunit
iii - block translocation of mRNA breaking up ribosomal clusters
Complete protein synthesis blockage. However ineffective against anaerobes as they need o2 dependent transporter to enter the cell
SE aminoglycosides
Ototoxic (Irreversible)
Nephrotoxic - usually reversible once stopped
Dose monitoring is crucial serum drug levels are taken 6-14hrs post dose when given OD, nomogram is then used to dictate subsequent frequency and dose.
Interactions of aminoglycosides
Increased risk of nephrotoxicity with NSAIDs, ACEi, increased risk of ototoxicity with vancomycin, diuretics
CI aminoglycosides
Renal failure, myasthenia gravis
Indications aminoglycosides
Endocarditis
Bilary infections and pyelonephritis
Pseudomonas infections
Sepsis
Macrolides
Clarthromycin, erythromycin and azithromycin
MOA macrolides
Target 50s subunit of ribosome preventing the transfer of bacterial tRNA from A site to P site on the ribosome thus preventing elongation of the polypeptide chain
Indications of macrolides
Good against gram +ve, gram -ve and atypical organisms as doesn’t act on the cell wall
Atypical LRTI (legionella, mycoplasma) and otitis media
H.pylori eradication therapy
Chlamydia trachomatis
Bordatella pertussis
SE of macrolides
QT prolongation with possibility of degeneration to torsdes de pointes
Hepatotoxic
N/V, diarrhoea and abdo pain